NOMAD Bioscience receives patents in Japan and Australia for its antibacterials Salmocins
NOMAD Bioscience GmbH has announced that the patent offices of Japan and Australia have issued the decisions to grant pa…
NOMAD Bioscience GmbH has announced that the patent offices of Japan and Australia have issued the decisions to grant pa…
NOMADS UAB, Lithuania, NOMAD Bioscience’s wholly owned subsidiary, announces publication in the Nature group journal Sci…
NOMAD has announced that the United States’ Patent and Trademark Office (USPTO) has issued the "Notice of Allowance" for…
NOMADS UAB, Vilnius, Lithuania (“NOMADS”), a wholly owned subsidiary of Nomad Bioscience GmbH, Munich, Germany, is pleas…
Nomad Bioscience GmbH (“NOMAD”) is pleased to announce that the Company has entered into a broad research and developmen…
NOMAD Bioscience received a formal ‘no questions’ letter from the US Food and Drug Administration (FDA) in response to N…
NOMAD has announced that the United States’ Patent and Trademark Office has issued the "Notice of Allowance" for the NOM…
NOMAD Bioscience received a formal ‘no questions’ letter from the US Food and Drug Administration (FDA) in response to N…
NOMADS UAB, Lithuania, NOMAD Bioscience’s wholly owned subsidiary, announces the publication in the PLOS One journal (Pa…
NOMAD Bioscience received a formal ‘no questions’ letter from the US Food and Drug Administration (FDA) in response to N…